Drreddys Laboratories reported $360M in Cash and Equivalent for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Ani Pharmaceuticals ANIP:US $ 15.25M 9.01M
Aurora Cannabis Inc ACB:CN 372.79M 48.67M
Bayer BAYN:GR € 4316M 927M
Canopy Growth Corp WEED:CN C$ 807.62M 615.06M
Catalent CTLT:US $ 1969M 1073M
Corcept Therapeutics CORT:US $ 94.69M 0.74M
Endo International Ordinary Shares ENDP:US $ 1568.66M 23.49M
GlaxoSmithKline GSK:LN 3453M 50M
Gw Pharmaceuticals GWPH:US $ 458.1M 28.65M
Hikma Pharmaceutical HIK:LN 2M 321M
Horizon Pharma HZNP:US $ 1068.55M 256.23M
Jazz Pharmaceuticals JAZZ:US 1000 0
Lannett LCI:US $ 105.32M 12.04M
Lonza Group LONN:SW 501M 6M
Novartis NOVN:VX SF 7211M 2094M
Pacira Pharmaceuticals PCRX:US $ 134.04M 28.26M
Phibro Animal Health PAHC:US $ 41.18M 9.04M
Prestige Brands PBH:US $ 42.82M 120.81M
Richter Gedeon RICHT:HB 59.24B 18.41B
Supernus Pharmaceuticals SUPN:US $ 215.28M 8.49M
Teva Pharmaceutical TEVA:IT 2.04B 391M